About Senseonics
Senseonics is a publicly listed company based in Germantown (United States) founded in 1996. Implantable continuous glucose monitoring systems are provided for diabetes management. It operates in the Healthcare and Technology sectors. Senseonics has raised $175.46 million across 17 funding rounds from investors including Oxford Finance, Greenspring Associates and Roche. The company has 117 employees. Its chief executive, as recorded, is Tim Goodnow. Its website senseonics.com draws about 15 thousand monthly visits. Senseonics offers products and services including Eversense CGM and Eversense System. Its focus areas include HealthTech, Disease Self Management, Diabetes and Monitoring. Its legal entity is SENSEONICS HOLDINGS, INC. Its competitors include Dexcom, Livongo and Bigfoot Biomedical; 3 of its 3 listed competitors have raised funding.
Company details
Senseonics was founded in 1996 and is headquartered in Germantown, United States. Continuous glucose monitoring systems for diabetes patients are designed, developed, and commercialized by the company. An implantable sensor, paired with a transmitter and mobile application, is utilized to track glucose levels for up to 90 days. The sensor is inserted into the upper arms subcutaneous tissue and transmits data wirelessly without batteries or wires.
- Headquarters Germantown, United States
- Employees 117
- Stage Public
- SectorsHealthcareTechnology
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website senseonics.com
- Social LinkedIn
- Legal Name Senseonics Holdings, Inc.
- Annual Revenue$22.47 M (USD)0.37as on Dec 31, 2024
- Net Profit-$78.62 M (USD)-30.18as on Dec 31, 2024
- EBITDA-$73.37 M (USD)1.29as on Dec 31, 2024
- Total Equity Funding$175.46M (USD)
in 17 rounds
- Latest Funding Round$20.27M (USD), Post-IPO
May 2025
- InvestorsOxford Finance
& 6 more
- Employee Count117
Products & Services of Senseonics
Senseonics offers a comprehensive portfolio of products and services, including Eversense CGM and Eversense System.
Implantable system for accurate long-term glucose tracking in diabetes patients.
Next-generation implantable sensor for up to 180-day continuous monitoring.
Funding Insights of Senseonics
Senseonics has successfully raised a total of $175.46M across 17 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20.27 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $175.46M
- Total Rounds 17
- Last Round Post-IPO — $20.27M
- First Round $15.24M
(Jun 2002)
- Investors Count 7
Latest 10 of 17 funding rounds of Senseonics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2025 | $20.27M | Post-IPO | – | – | – |
| Oct 2024 | $16M | Post-IPO | – | – | – |
| Jan 2021 | $50M | Post-IPO | – | – | – |
| Aug 2020 | $3M | Post-IPO | – | – | – |
| May 2017 | $41M | Post-IPO | – | – | |
| Aug 2015 | $10M | Series F | – | – | |
| Aug 2015 | $10M | Series C | – | – | – |
| Aug 2014 | $10M | Debt – Conventional | – | – | |
| Aug 2014 | $299,991 | Series E | – | – | – |
| Jul 2014 | $299,991 | Series C | – | – | – |
7 investors in total: 7 institutional.
Investors in Senseonics
Senseonics has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Oxford Finance, Greenspring Associates and Roche.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital firm focused on the healthcare sector | roche.com/venturefund.htm | |||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
| anthemcapital.ca | ||||
Investments are made in life sciences firms across all stages. | delphiventures.com | Menlo Park, United States | ||
Diversified investment management firm | 2000 | greenspringassociates.com | Owings Mills, United States | |
| hcven.com |
Investor details for Senseonics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Senseonics
79 people are tracked at Senseonics (27 in leadership, 8 in board & advisors, 44 in team); the tracked headcount is 117.
| Name | Role | Group |
|---|---|---|
Tim Goodnow | CEO & President | Leadership |
Brian Thomas | Director Of Engineering | Leadership |
Timothy Goodnow | President & CEO | Leadership |
Rick Sullivan | CFO | Leadership |
Abhi Chavan | VP, Engineering, R&D | Leadership |
Francine R. Kaufman | Chief Medical Officer | Leadership |
Mukul Jain | COO | Leadership |
Katherine S. Tweden | VP, Clinical Sciences | Leadership |
Emilie Balkman | Director, Clinical Strategy & Programs | Leadership |
Jeff Ruiz | Head Of Strategy And Commercial Business Development | Leadership |
Vallikannu Somasundaram | Sr. Director, Quality Sciences | Leadership |
Madeline Newland | Sr. Director Global Customer Support | Leadership |
Michelle Boie | Senior Director Of Operations | Leadership |
Hari Sree | Vice President Of Product Development | Leadership |
Kathleen Davis | Sr. Director, Clinical Operations | Leadership |
Dawit Belete | Director, Quality Sciences | Leadership |
Colleen Mdingi | Director, Clinical Data Managment | Leadership |
Maggie Lewis | Director Of Clinical Operations | Leadership |
Chris Stanislawczyk | Director, Manufacturing & Supply Chain | Leadership |
Kelly Joy | Vp, Commercial & Alliance Operations | Leadership |
59 more people are available in the full profile.
Complete people profiles for Senseonics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Senseonics
Senseonics is a publicly listed company on the AMEX with ticker symbol SENS in USA, operating in the Electronic technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Mar 2017
- Listed onFRA: 6L6
- Listed entitySenseonics Holdings, Inc.
- Exchange sectorElectronic technology
- ISINUS81727U3032
- Share price$6.26 (+1.29% on the day) · 2025-11-16
- Market capitalisation$255.8M
- EPS (diluted, trailing year)$-1.71
- Volume (last session)477,754
- Analyst consensusBuy
Financials of Senseonics
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | $22.5M | -$78.6M | -$73.4M |
| 2023 | $22.4M | -$60.4M | -$74.3M |
| 2022 | $16.4M | $142.1M | -$67.6M |
| 2021 | $13.7M | -$302.5M | -$55.9M |
| 2020 | $5.0M | -$175.2M | -$78.0M |
Detailed financial statements for Senseonics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Senseonics
4 dated milestones of Senseonics across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Senseonics is founded.
- Funding First funding round of $15.2M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $20.3M.
Competitors of Senseonics
Senseonics has 3 listed competitors in our database, 3 of them funded. They include Dexcom, Livongo and Bigfoot Biomedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $237M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| bigfootbiomedical.com | 2014 | Milpitas, United States | $214.51M | 133 | Developer of a closed-loop automated insulin delivery system |
Detailed competitors of Senseonics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Senseonics
The website of Senseonics (senseonics.com) receives about 15.2K visits a month and ranks #1,883,577 among all websites worldwide, #2,568 in Biotechnology and Pharmaceuticals.
- Monthly visits15.2K
▲ 7.7% vs previous month
- Unique visitors6.1K
per month
- Global rank#1,883,577
among all websites
- Category rank#2,568
Health · Biotechnology and Pharmaceuticals
- Bounce rate46%
- Pages per visit1.4
- Average visit8 sec
- DevicesDesktop 30% · Mobile 70%
Websites whose visitors overlap most with Senseonics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| selectabio.com | 100% | View details | |||
ppdi.com | ppdi.com | 100% | #404,899 | – | |
| ascensia.com | 81% | #669,809 | View details | ||
| helena-biosciences.com | 71% | #8,736,284 | View details | ||
wexlersurgical.com | wexlersurgical.com | 69% | #1,968,723 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Senseonics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diabetes
3 companies that operate in the same segment as Senseonics (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Senseonics
Complete news archive for Senseonics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Senseonics
Senseonics was founded in 1996 and raised its 1st funding round 6 years after it was founded.
Senseonics is headquartered in Germantown, United States.
Tim Goodnow is the CEO of Senseonics, as recorded in our data.
Senseonics is a funded company, having raised a total of $175.46M across 17 funding rounds to date. The company's 1st funding round was a Series C of $299.99K, raised on Jun 2002.
Senseonics has 117 employees.
Annual revenue of Senseonics is $22.47M as on Dec 31, 2024.
Senseonics was founded in 1996 and is headquartered in Germantown, United States. Continuous glucose monitoring systems for diabetes patients are designed, developed, and commercialized by the company. An implantable sensor, paired with a transmitter and mobile application, is utilized to track glucose levels for up to 90 days. The sensor is inserted into the upper arms subcutaneous tissue and transmits data wirelessly without batteries or wires.
Senseonics's top competitors include Dexcom, Bigfoot Biomedical and Livongo.
Senseonics offers Eversense CGM and Eversense System.
Yes, Senseonics is publicly traded on AMEX under the ticker symbol SENS.
Senseonics has 7 investors. Key investors include Oxford Finance, Greenspring Associates, Roche, NEA, and Anthem Capital.
Senseonics operates through Senseonics Holdings, Inc.